Washington Trust Advisors’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.22K | Hold |
342
| – | – | ﹤0.01% | 606 |
|
|
2025
Q1 | $2.71K | Hold |
342
| – | – | ﹤0.01% | 592 |
|
|
2024
Q4 | $4.33K | Hold |
342
| – | – | ﹤0.01% | 584 |
|
|
2024
Q3 | $4.77K | Buy |
342
+96
| +39% | +$1.34K | ﹤0.01% | 580 |
|
|
2024
Q2 | $3.39K | Hold |
246
| – | – | ﹤0.01% | 603 |
|
|
2024
Q1 | $4.06K | Hold |
246
| – | – | ﹤0.01% | 595 |
|
|
2023
Q4 | $3.59K | Hold |
246
| – | – | ﹤0.01% | 606 |
|
|
2023
Q3 | $3.02K | Hold |
246
| – | – | ﹤0.01% | 609 |
|
|
2023
Q2 | $2.94K | Buy |
246
+83
| +51% | +$991 | ﹤0.01% | 604 |
|
|
2023
Q1 | $2.18K | Hold |
163
| – | – | ﹤0.01% | 719 |
|
|
2022
Q4 | $3.51K | Hold |
163
| – | – | ﹤0.01% | 656 |
|
|
2022
Q3 | $3K | Hold |
163
| – | – | ﹤0.01% | 790 |
|
|
2022
Q2 | $3K | Buy |
+163
| New | +$3K | ﹤0.01% | 818 |
|